Viemed Healthcare, Inc.
VMD Healthcare Medical Devices
Viemed Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $270.3 million, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 23.9%, EPS fell 12.5%, free cash flow fell 18.2% and total debt rose 65.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow VMD
Viemed Healthcare, Inc. (VMD) P/E ratio
As of 16 October 2026, Viemed Healthcare, Inc. (VMD) trades at a P/E ratio of 24.9×. Over the past ten years it has ranged from 8.0× (January 2018) to 1,111,111× (April 2017); the current reading is higher than 40% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 19.1× | (31.11%) |
| FY2024 | 27.7× | (6.55%) |
| FY2023 | 29.6× | (41.21%) |
| FY2022 | 50.3× | 121.77% |
| FY2021 | 22.7× | 136.90% |
| FY2020 | 9.6× | (63.66%) |
| FY2019 | 26.4× | (99.99%) |
| FY2018 | 267,500× | 3,324,533.36% |
| FY2017 | 8.0× | (100.00%) |
| FY2016 | 1,104,377× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 30.0× | 27.04% |
| Mar 2026 | 23.6× | 23.96% |
| Dec 2025 | 19.1× | (1.80%) |
| Sep 2025 | 19.4× | 1.07% |
| 30 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NPCE NeuroPace, Inc. compare | n/m |
| SENS Senseonics Holdings, Inc. compare | n/m |
| OFIX ORTHOFIX MEDICAL INC. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| CLPT ClearPoint Neuro, Inc. compare | n/m |
| RCEL Avita Medical Inc. compare | n/m |
| SI Shoulder Innovations, Inc. compare | n/m |
| CV CapsoVision, Inc. compare | 2.1× |
| VMD Viemed Healthcare, Inc. | 24.9× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)